Erasca Raises $200 Million Series B Financing By Jonathan Lim, M.D.|2020-08-31T08:52:51-07:00April 27, 2020|
ORIC Pharmaceuticals Announces Pricing of Initial Public Offering By Araceli Richardson|2020-08-18T00:57:30-07:00April 23, 2020|
Chugai Obtains Approval for Additional Indication of Rozlytrek for ROS1 Fusion-Positive Non-Small Cell Lung Cancer By Araceli Richardson|2020-08-18T00:57:30-07:00February 21, 2020|
Black Diamond Therapeutics Announces Pricing of Initial Public Offering By Araceli Richardson|2020-08-18T00:57:30-07:00January 29, 2020|
Black Diamond Therapeutics Closes $85 Million Series C Financing By Araceli Richardson|2020-08-18T00:57:30-07:00December 5, 2019|
Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA By Araceli Richardson|2020-08-18T00:57:30-07:00September 19, 2019|
FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor By Araceli Richardson|2020-08-18T00:57:30-07:00August 15, 2019|
ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance By Araceli Richardson|2020-08-18T00:57:31-07:00August 8, 2019|
Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek By Araceli Richardson|2020-08-18T00:57:31-07:00June 18, 2019|
OncoMyx Therapeutics Completes $25 Million Series A Financing By Araceli Richardson|2020-08-18T00:57:31-07:00June 5, 2019|
